The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Base excision repair (BER) inhibitor TRC 102 (Methoxyamine) combined with pemetrexed (PEM)-based chemo-radiation (CRT) for locally advanced non-squamous non-small cell lung cancer (NS-NSCLC): Results of a phase I trial.
 
Tithi Biswas
No Relationships to Disclose
 
Afshin Dowlati
No Relationships to Disclose
 
Charles Kunos
No Relationships to Disclose
 
John Pink
No Relationships to Disclose
 
Nancy Oleinick
No Relationships to Disclose
 
Shakun M. Malik
No Relationships to Disclose
 
Pingfu Fu
No Relationships to Disclose
 
Debora S. Bruno
No Relationships to Disclose
 
David Lawrence Bajor
Consulting or Advisory Role - BridgeBio Pharma; Cardinal Health
Research Funding - Apexigen; Roche/Genentech; Seagen; Tesaro
 
Monaliben Patel
No Relationships to Disclose
 
Mitchell Machtay
No Relationships to Disclose